2011《财富》美国500强10大牛股
MAUREEN FARRELL/ HIBAH YOUSUF | 2011-12-21 15:47
分享:
[译文]
Flying high
From 30,000 feet, this year's volatile swings in the stock market don't look as bad, with the S&P 500 down only 3% for the year.
Fortune 500 companies took the middle ground, with half of those companies posting gains. Roughly 30% enjoyed double-digit percentage stock increases.
Among the best performers were companies like MasterCard, which benefited because a change to debit fee regulation was not as bad as first feared. Retailers also fared well as consumers began to loosen those proverbial purse strings.
Click through to see the top 10 Fortune 500 performers (counting down from good to great), based on their closing prices as of Dec. 9.
#10 Centene
Ticker: CNC
YTD stock performance: 48%
Market cap: $1.8 billion
Fortune 500 Rank: 493
Shares of Centene, which provides managed care programs and related services to individuals under Medicaid, surged as the company continued to add more members and expand into new states, including Florida, Illinois, Mississippi and Texas.
In its last quarterly report, St. Louis-based Centene boasted 1.6 million members, up almost 8% from a year ago. Investors were also pleased that the company raised its outlook for the year.
Centene's stock has also benefited from talk that the managed-care provider could be ripe for a takeover, following a slew of acquisitions by major health insurers of smaller companies that specialize in covering Medicaid patients.
Wells Fargo analysts say the company is also likely to benefit from health reform, since it is set to substantially expand Medicaid eligibility. Cash-strapped states have already started looking into shifting recipients to managed-care providers, which have promised to keep costs low.
#9 Targa Resources Corp.
Ticker: TRGP
YTD stock performance: 48%
Market cap: $1.6 billion
Fortune 500 Rank: 416
Tired of virtually record-low interest rates, income-hungry investors have been on the hunt for dividend stocks, including Targa Resources Corp, which made its public debut in December 2010 and yields a quarterly dividend of more than 3%.
At the start of this month, Targa said it may increase dividend payments by as much as 40% next year, thanks to growth at Targa Resources Partners, which provides natural gas and natural gas liquid services across the country through a limited partnership.
Houston-based Targa also announced major management changes this month that helped boost the stock price. Barclays analysts expect the momentum to continue, targeting the stock at $59 per share, at 53% jump from current levels.
#8 Ross Stores
Ticker: ROST
YTD stock performance: 50%
Market cap: $10.5 billion
Fortune 500 Rank: 303
As high employment continues to plague the nation, Americans have been shopping for bargains. That helped Ross Stores, which sells brand-name merchandise at discounts between 20% and 70%, generate strong sales growth every quarter this year.
During both the second and third quarter of the year, when signs of a slowing economy were in the spotlight, overall revenue jumped by a robust 9% during each three-month period, while same-stores sales, a key measure for retailers, grew at a healthy 5%.
Though the discount retailer boasts store locations across 27 states and Guam, it continues to notably grow in big markets. Ross recently opened 12 new stores in Chicago, and has significant plans to expand across the Midwest.
#7 Oneok
Ticker: OKE
YTD stock performance: 55%
Market cap: $8.4 billion
Fortune 500 Rank: 189
As fears of a double-dip recession and Europe's debt crisis gripped markets, investors got defensive and shifted into safe investments, including utilities and dividend-paying stocks. That dynamic favored shares of Tulsa-based Oneok, which distributes natural gas to more than 2 million customers throughout Oklahoma, Texas and Kansas, and pays a dividend of 3%.
Investors are particularly attracted to utility companies when the economic outlook seems dim, since consumers are always in need of gas and electricity.
The company also benefits from its stake in Oneok Partners, which gathers, processes, stores and transports natural gas across the country.
Oneok's stock began to take off in September, after the company raised its 2012 earnings forecast, citing a boost from recently completed projects in the Bakken Shale, Cana-Woodford Shale and Granite Wash oil fields.
#6 Humana
Ticker: HUM
YTD stock performance: 56%
Market cap: $13.8 billion
Fortune 500 Rank: 79
As the second-largest provider of Medicare's managed care plans in the United States, Humana is well positioned to take advantage of the flood of baby boomer retirees.
Roughly 1.9 million Americans are covered by its Medicare Advantage health insurance plans already.
New retirees are already boosting the company's revenues and profitability. Humana reported an 11% jump in third quarter revenue and boosted its 2012 earnings-per-share outlook by roughly 56% after enrollment outpaced the company's earlier forecasts.
Like other companies in the managed care sector, Humana's stock took a hit between 2008 and 2010 as investors feared the effects of health care reform. As the broad outlines of health care reform looked less punitive than expected for managed care companies, investors spent 2011 racing back into the sector.
The company will be undergoing a management shift in the next year. Chief Executive Michael McCallister plans to retire after a decade of serving at the firm's helm.
#5 VF Corp.
Ticker: VFC
YTD stock performance: 62%
Market cap: $14.4 billion
Fortune 500 Rank: 310
VF is the company behind a number of popular brands, including The North Face, Seven for all Mankind, Wrangler, and Vans. In June, VF made a huge move by adding Timberland to its impressive roll.
That acquisition cost VF about $2 billion in cash, but is a "game-changing" one that will spur substantial growth for the next several years, according to Morgan Stanley analysts, who target VF's stock price at $152 per share.
VF said in October that Timberland, which has a strong international presence, added almost $164 million to the company's third-quarter revenue of $2.8 billion. VF CEO Eric Wiseman said he expects that momentum to continue, and boosted the company's fourth-quarter guidance substantially, citing the "transformational" buyout.
Investors are also fans of Greensboro, N.C.-based VF because of its reliable dividend payouts. VF recently marked its 39th consecutive year of higher dividend payments, when it raised its quarterly disbursement 14% to 72 cents per share.
#4 BioGen
Ticker: BIIB
YTD stock performance: 69%
Market cap: $26.6 billion
Fortune 500 Rank: 476
Shares of pharmaceutical maker BioGen spiked on hopes that the company could get its multiple sclerosis pill, BG-12, approved by the Food and Drug Administration.
BioGen develops treatments for multiple sclerosis, cancer and other diseases. Investors are most focused on the prospects for BioGen's MS treatment as analysts have speculated that it could be a billion dollar drug.
In October, BioGen said that patients using BG-12 during a third clinical trial showed significant drops in MS relapse rates.
Analysts estimate that BG-12 could be a $2 billion to $3 billion drug, and become the primary treatment for most MS sufferers. BioGen plans to file for approval with the FDA in early 2012.
BG-12 would round out the company's existing drug portfolio, which helped boost BioGen's third-quarter net income by 38%.
#3 MasterCard
Ticker: MA
YTD stock performance: 69%
Market cap: $43.8 billion
Fortune 500 Rank: 410
The shift to a cashless society has been a boon for credit card companies and helped insulate them from the economic downturn.
For MasterCard, both the number of transactions and their dollar value jumped more than 18% in the third quarter.
MasterCard is the credit card provider best positioned to capture an outsize share of the growing pie of swipes. It has the largest share of customers in emerging markets with roughly half of the company's revenue coming from outside the United States.
MasterCard has also been aggressively investing in technology and expanding partnerships to boost its presence on mobile platforms. Its PayPass technology works with Google's Android Wallet application.
Meanwhile all debit-card companies declared victory on regulations related to debit-card fees. On June 30, the Federal Reserve decided that banks could charge fees of up to 45 cents for a debit-card purchase. That's double the original limits proposed under Dodd-Frank regulatory reform.
#2 El Paso
Ticker: EP
YTD stock performance: 81%
Market cap: $19.2 billion
Fortune 500 Rank: 481
The Houston, Texas-based natural gas company announced in October that it had accepted a $21 billion buyout offer from Kinder Morgan, a larger and more diversified energy company.
After moving up steadily for much of 2011, the company's shares shot up after the acquisition was announced and stayed there. (Shares of most of its competitors, which were suddenly deemed takeover targets, did too).
Should it close as expected in early 2012, El Paso's merger with Kinder Morgan would create the largest natural gas pipeline in the US.
Aside from El Paso's lucrative sales price, it's been a good year for natural gas producers overall, thanks to an uptick in demand for domestic gas.
It's not all smooth sailing. Environmentalists continue to push against "fracking," a process that injects water, sand and chemicals deep into the ground to break up the shale and release natural gas. Opponents say the process is contaminating drinking water and polluting the air.
#1 WellCare Health Plans
Ticker: WCG
YTD stock performance: 93%
Market cap: $2.2 billion
Fortune 500 Rank: 420
As the first wave of baby boomers turns 65, WellCare is well poised to boost to take advantage. The Tampa, Fla., managed-care provider is the fourth-largest provider of Medicare Advantage insurance plans to seniors in the United States.
Medicare Advantage, also known as Medicare Part C, is another option for Medicare recipients that mirror traditional insurance plans or offer supplemental coverage.
In April, WellCare settled a 2008 fraud scandal involving falsifying health records. The settlement cleared the way for WellCare to once again be a government contractor for the Medicare and Medicaid programs.
WellCare's enrollments jumped 10% in the third quarter, mostly due to an increase in Medicare Advantage members. The increase helped the firm nearly double its third-quarter profits and raise its outlook.
WellCare also become a possible takeover target. Major health insurers have been scrambling to increase their market share in privately-managed Medicare plans, with UnitedHealth Care and Cigna (CI) already acquiring large Medicare Advantage providers this year.

高高飞翔 从3万英尺的高空俯视,今年股市的跌宕起伏看来还不算太坏,标准普尔500指数今年也只跌了3%。 《财富》美国500强公司的表现处在中游,其中半数公司股价上涨。约30%的公司获得了两位数的涨幅。 表现最佳的公司包括万事达(MasterCard);借记卡收费改革没有像最初担心得那么糟糕,令其受益。零售商的状况也不错,消费者开始放松捂紧的钱包。 以下是2011年《财富》美国500强中涨幅最大的十只股票(从第十名到第一名排列),以12月9日收盘价计算涨幅。 | Flying high From 30,000 feet, this year's volatile swings in the stock market don't look as bad, with the S&P 500 down only 3% for the year. Fortune 500 companies took the middle ground, with half of those companies posting gains. Roughly 30% enjoyed double-digit percentage stock increases. Among the best performers were companies like MasterCard, which benefited because a change to debit fee regulation was not as bad as first feared. Retailers also fared well as consumers began to loosen those proverbial purse strings. Click through to see the top 10 Fortune 500 performers (counting down from good to great), based on their closing prices as of Dec. 9. |

第10名:Centene医疗补助保险公司 交易代码: CNC 年初至今股票涨幅:48% 市值: 18亿美元 500强排名:493 Centene提供医疗补助(Medicaid)管理式医疗计划和相关服务。今年它的参保人数持续增加,业务也拓展至佛罗里达州、伊利诺伊州、密西西比州和德克萨斯州等地,公司股价迎来大幅上涨。 总部位于圣路易斯的Centene在最近一期季报中宣称拥有160万人参保,较一年前增加了近8%。投资者也很高兴看到该公司上调了全年业绩指导值。 推动Centene股价上扬的因素的还包括收购传闻。几家大型健康保险公司收购了一些专为医疗补助患者服务的中小公司后,据称收购这家管理式医疗计划提供商的时机也已经成熟。 富国银行(Wells Fargo)的分析师们表示,该公司也可能受益于医疗改革,因为改革将大大放宽医疗补助的参保符合条件。一些现金紧缺的州政府早已开始考虑将医疗补助的参保人群交给承诺控制成本的管理式医疗计划提供商。 | #10 Centene Ticker: CNC YTD stock performance: 48% Market cap: $1.8 billion Fortune 500 Rank: 493 Shares of Centene, which provides managed care programs and related services to individuals under Medicaid, surged as the company continued to add more members and expand into new states, including Florida, Illinois, Mississippi and Texas. In its last quarterly report, St. Louis-based Centene boasted 1.6 million members, up almost 8% from a year ago. Investors were also pleased that the company raised its outlook for the year. Centene's stock has also benefited from talk that the managed-care provider could be ripe for a takeover, following a slew of acquisitions by major health insurers of smaller companies that specialize in covering Medicaid patients. Wells Fargo analysts say the company is also likely to benefit from health reform, since it is set to substantially expand Medicaid eligibility. Cash-strapped states have already started looking into shifting recipients to managed-care providers, which have promised to keep costs low. |

第9名:Targa Resources Corp. 能源公司 交易代码: TRGP 年初至今股票涨幅:48% 市值: 16亿美元 500强排名:416 渴望收益的投资者们厌倦了创下新低的利率,一直在物色高派息股票,其中酒包括Targa Resources Corp能源公司。这家公司于2010年12月首次公开募股,季度派息率超过3%。 本月初,Targa表示,由于Targa Resources Partners天然气公司的增长,明年可能增加派息达40%; Targa Resources Partners通过有限合伙方式在全美提供天然气和液化天然气服务。 本月,总部位于休斯顿的Targa还宣布了管理层重大调整的消息,帮助推高了该股股价。巴克莱(Barclays)分析师们预计,这支股票的涨势将会得到延续,他们给出的目标价为59美元,较该股当前价位高出53%。 | #9 Targa Resources Corp. Ticker: TRGP YTD stock performance: 48% Market cap: $1.6 billion Fortune 500 Rank: 416 Tired of virtually record-low interest rates, income-hungry investors have been on the hunt for dividend stocks, including Targa Resources Corp, which made its public debut in December 2010 and yields a quarterly dividend of more than 3%. At the start of this month, Targa said it may increase dividend payments by as much as 40% next year, thanks to growth at Targa Resources Partners, which provides natural gas and natural gas liquid services across the country through a limited partnership. Houston-based Targa also announced major management changes this month that helped boost the stock price. Barclays analysts expect the momentum to continue, targeting the stock at $59 per share, at 53% jump from current levels. |

第8名:罗斯服饰零售公司 交易代码: ROST 年初至今股票涨幅:50% 市值:105亿美元 500强排名:303 高失业率依然困扰着美国,美国人买东西也挑便宜货。这种情况让以3-8折出售品牌商品的罗斯公司受益匪浅,该公司今年每个季度的销售额都有强劲增长。 今年第二、第三季度,美国经济放缓迹象备受关注,然而罗斯公司在这两个季度的总营收分别劲升了9%,零售商的关键指标——同店销售额也有5%的良好增幅。 虽然这家折扣零售商在美国27个州和关岛都已设有门店,但在大市场仍有显著成长。罗斯最近在芝加哥新开了12家店,并制定了宏伟的蓝图,有意将业务拓展至整个中西部地区。 | #8 Ross Stores Ticker: ROST YTD stock performance: 50% Market cap: $10.5 billion Fortune 500 Rank: 303 As high employment continues to plague the nation, Americans have been shopping for bargains. That helped Ross Stores, which sells brand-name merchandise at discounts between 20% and 70%, generate strong sales growth every quarter this year. During both the second and third quarter of the year, when signs of a slowing economy were in the spotlight, overall revenue jumped by a robust 9% during each three-month period, while same-stores sales, a key measure for retailers, grew at a healthy 5%. Though the discount retailer boasts store locations across 27 states and Guam, it continues to notably grow in big markets. Ross recently opened 12 new stores in Chicago, and has significant plans to expand across the Midwest. |

第7名:Oneok燃气公司 交易代码: OKE 年初至今股票涨幅: 55% 市值: 84亿美元 500强排名: 189 由于担心美国经济可能陷入二次衰退,再加上欧债危机,投资者转为防御型,纷纷转向包括公用事业股和高派息股在内的安全投资。这个趋势对总部位于塔尔萨的Oneok股价十分有利。Oneok公司向俄克拉荷马州、德克萨斯州和堪萨斯州超过200万用户输送天然气,派息率3%。 经济前景黯淡时,投资者们特别青睐公用事业公司,因为不管什么时候,消费者们总得用电用气。 这家公司还参股了全美天然气采集、处理和运输公司Oneok Partners,同样获得了收益。 Oneok股价的飙升始于9月份,当时它上调了2012年盈利预测,原因是近期完工的Bakken Shale, Cana-Woodford Shale和Granite Wash油田项目将提振产量。 | #7 Oneok Ticker: OKE YTD stock performance: 55% Market cap: $8.4 billion Fortune 500 Rank: 189 As fears of a double-dip recession and Europe's debt crisis gripped markets, investors got defensive and shifted into safe investments, including utilities and dividend-paying stocks. That dynamic favored shares of Tulsa-based Oneok, which distributes natural gas to more than 2 million customers throughout Oklahoma, Texas and Kansas, and pays a dividend of 3%. Investors are particularly attracted to utility companies when the economic outlook seems dim, since consumers are always in need of gas and electricity. The company also benefits from its stake in Oneok Partners, which gathers, processes, stores and transports natural gas across the country. Oneok's stock began to take off in September, after the company raised its 2012 earnings forecast, citing a boost from recently completed projects in the Bakken Shale, Cana-Woodford Shale and Granite Wash oil fields. |

第6名:Humana医疗健康服务公司 交易代码: HUM 年初至今股票涨幅: 56% 市值: 138亿美元 500强排名: 79 Humana医疗健康服务公司是全美第二大医疗补助管理式医疗计划提供商,大批婴儿潮一代进入退休年龄势必对它极为有利。 Humana公司的Medicare Advantage健康保险计划参保人数已经高达约190万人。 新近退休的人群持续推高了公司的营收和利润。Humana公司公布,今年第三季度营收增长了11%;由于参保人数超过公司预期,公司还将2012年每股收益预测上调了约56%。 提供管理式医疗计划的公司股价在2008-2010年间也出现了大跌,Humana同样未能幸免,因为当时投资者担心医保改革带来的不利效应。但是医保改革框架似乎对管理式医疗计划行业的冲击不如想象的那么大,2011年投资者开始加速重返这一板块。 明年Humana的管理层将有所调整。首席执行官迈克•麦卡利斯特执掌公司十年后,计划退休。 | #6 Humana Ticker: HUM YTD stock performance: 56% Market cap: $13.8 billion Fortune 500 Rank: 79 As the second-largest provider of Medicare's managed care plans in the United States, Humana is well positioned to take advantage of the flood of baby boomer retirees. Roughly 1.9 million Americans are covered by its Medicare Advantage health insurance plans already. New retirees are already boosting the company's revenues and profitability. Humana reported an 11% jump in third quarter revenue and boosted its 2012 earnings-per-share outlook by roughly 56% after enrollment outpaced the company's earlier forecasts. Like other companies in the managed care sector, Humana's stock took a hit between 2008 and 2010 as investors feared the effects of health care reform. As the broad outlines of health care reform looked less punitive than expected for managed care companies, investors spent 2011 racing back into the sector. The company will be undergoing a management shift in the next year. Chief Executive Michael McCallister plans to retire after a decade of serving at the firm's helm. |

第5名:VF 服饰公司 交易代码: VFC 年初至今股票涨幅: 62% 市值: 144亿美元 500强排名: 310 VF旗下有The North Face、Seven for all Mankind、Wrangler和Vans等众多知名品牌。今年6月,VF又在这个星光熠熠的名单上增加了Timberland。 这笔收购耗费了VF约20亿美元现金,但摩根士丹利(Morgan Stanley)分析师们认为,它“将改变行业格局”,推动公司未来几年业绩大幅增长;摩根士丹利给出的VF目标价是每股152美元。 10月份,VF宣布,国际市场大卖的Timberland为公司第三季度贡献了近1.64亿美元收入,当季总营收28亿美元。VF首席执行官艾瑞克•怀斯曼预计这一势头将持续下去。鉴于此次“变革性的”收购,他大幅调高了公司第四季度指导值。 总部位于北卡罗来纳州格林伯勒的VF派息稳定,因此也深受投资者喜欢。最近,VF已是连续第三十九年增加派息,将季度派息调高了14%至每股72美分。 | #5 VF Corp. Ticker: VFC YTD stock performance: 62% Market cap: $14.4 billion Fortune 500 Rank: 310 VF is the company behind a number of popular brands, including The North Face, Seven for all Mankind, Wrangler, and Vans. In June, VF made a huge move by adding Timberland to its impressive roll. That acquisition cost VF about $2 billion in cash, but is a "game-changing" one that will spur substantial growth for the next several years, according to Morgan Stanley analysts, who target VF's stock price at $152 per share. VF said in October that Timberland, which has a strong international presence, added almost $164 million to the company's third-quarter revenue of $2.8 billion. VF CEO Eric Wiseman said he expects that momentum to continue, and boosted the company's fourth-quarter guidance substantially, citing the "transformational" buyout. Investors are also fans of Greensboro, N.C.-based VF because of its reliable dividend payouts. VF recently marked its 39th consecutive year of higher dividend payments, when it raised its quarterly disbursement 14% to 72 cents per share. |

第4名:BioGen制药公司 交易代码: BIIB 年初至今股票涨幅: 69% 市值: 266亿美元 500强排名: 476 制药公司BioGen的股价上涨是源于其治疗多发性硬化症的药物BG-12有希望获得美国食品和药物管理局(Food and Drug Administration)的批准。 BioGen开发治疗多发性硬化症、癌症和其他疾病的药物。投资者最关注的是BioGen治疗多发性硬化症药物的前景,分析师们预测这款药物的市场规模可能高达数十亿美元。 10月份,BioGen宣布,三期临床试验显示,服用BG-12的患者其多发性硬化症复发率显著下降。 分析师们估计BG-12的市场规模可能达到20-30亿美元,成为大多数多发性硬化症患者的主要治疗用药。BioGen计划2012年初向美国食品和药物管理局提交新药申报。 BG-12将丰富该公司现有的药品组合。凭借现有的药品组合,BioGen第三季度净利润增长了38%。 | #4 BioGen Ticker: BIIB YTD stock performance: 69% Market cap: $26.6 billion Fortune 500 Rank: 476 Shares of pharmaceutical maker BioGen spiked on hopes that the company could get its multiple sclerosis pill, BG-12, approved by the Food and Drug Administration. BioGen develops treatments for multiple sclerosis, cancer and other diseases. Investors are most focused on the prospects for BioGen's MS treatment as analysts have speculated that it could be a billion dollar drug. In October, BioGen said that patients using BG-12 during a third clinical trial showed significant drops in MS relapse rates. Analysts estimate that BG-12 could be a $2 billion to $3 billion drug, and become the primary treatment for most MS sufferers. BioGen plans to file for approval with the FDA in early 2012. BG-12 would round out the company's existing drug portfolio, which helped boost BioGen's third-quarter net income by 38%. |

第3名:万事达卡 交易代码: MA 年初至今股票涨幅: 69% 市值: 438亿美元 500强排名: 410 社会向电子支付的转型极大地推动了信用卡公司的发展,同时也减轻了经济滑坡给它们带来的冲击。 第三季度,万事达卡的交易量和交易额增幅均超过18%。 刷卡市场日益壮大,而万事达卡是最有希望夺取超高市场份额的信用卡公司。它在新兴市场中的客户占有的份额最大,公司约一半的营收都来自美国以外的地区。 万事达卡还积极投资技术,扩大合作,以扩大在移动平台上的影响力。它的PayPass技术可与谷歌(Google)的安卓钱包应用软件配套使用。 与此同时,借记卡行业还取得了“借记卡收费上限”之争的胜利。6月30日,美联储(Federal Reserve)宣布银行可对借记卡购物交易收取最高45美分的费用,这是多德-弗兰克监管改革方案最初建议上限的两倍。 | #3 MasterCard Ticker: MA YTD stock performance: 69% Market cap: $43.8 billion Fortune 500 Rank: 410 The shift to a cashless society has been a boon for credit card companies and helped insulate them from the economic downturn. For MasterCard, both the number of transactions and their dollar value jumped more than 18% in the third quarter. MasterCard is the credit card provider best positioned to capture an outsize share of the growing pie of swipes. It has the largest share of customers in emerging markets with roughly half of the company's revenue coming from outside the United States. MasterCard has also been aggressively investing in technology and expanding partnerships to boost its presence on mobile platforms. Its PayPass technology works with Google's Android Wallet application. Meanwhile all debit-card companies declared victory on regulations related to debit-card fees. On June 30, the Federal Reserve decided that banks could charge fees of up to 45 cents for a debit-card purchase. That's double the original limits proposed under Dodd-Frank regulatory reform. |

第2名:El Paso 交易代码: EP 年初至今股票涨幅: 81% 市值: 192亿美元 500强排名: 481 这家总部位于德克萨斯州休斯顿的天然气公司10月份宣布,已接受规模更大、业务更多元化的能源公司Kinder Morgan210亿美元全盘收购的要约。 El Paso的股价在2011年大部分时间都维持了稳步走高的趋势,收购消息宣布后,公司股价更是一飞冲天,并保持高位运行。(大多数突然被视为收购目标的同业股票也是如此。) 如果收购于2012年年初完成,El Paso与Kinder Morgan的联姻将诞生美国最大的天然气管道公司。 El Paso自然卖了个好价钱,但由于美国国内天然气需求上升,今年整体上对于天然气生产商而言也是不错的一年。 当然也不全都是一帆风顺。环保主义者继续反对“压裂法”,这种工艺将水、沙子和化学品泵入深层地下、压断页岩,从而释放出天然气。反对者认为,这种工艺会污染饮用水和空气。 | #2 El Paso Ticker: EP YTD stock performance: 81% Market cap: $19.2 billion Fortune 500 Rank: 481 The Houston, Texas-based natural gas company announced in October that it had accepted a $21 billion buyout offer from Kinder Morgan, a larger and more diversified energy company. After moving up steadily for much of 2011, the company's shares shot up after the acquisition was announced and stayed there. (Shares of most of its competitors, which were suddenly deemed takeover targets, did too). Should it close as expected in early 2012, El Paso's merger with Kinder Morgan would create the largest natural gas pipeline in the US. Aside from El Paso's lucrative sales price, it's been a good year for natural gas producers overall, thanks to an uptick in demand for domestic gas. It's not all smooth sailing. Environmentalists continue to push against "fracking," a process that injects water, sand and chemicals deep into the ground to break up the shale and release natural gas. Opponents say the process is contaminating drinking water and polluting the air. |

第1名:WellCare Health Plans健康保险公司 交易代码: WCG 年初至今股票涨幅: 93% 市值: 22亿美元 500强排名: 420 第一波婴儿潮一代正在迈入65岁,WellCare势必迎来巨大利好。这家总部位于佛罗里达州坦帕的管理式医疗计划提供商是美国医疗照顾优先计划(Medicare Advantage)的第四大提供商,这种保险计划主要面向老年人。 医疗照顾优先计划亦称为Medicare Part C,是为医疗照顾参与者提供的又一种选择,与传统保险计划一样或提供补充保险。 4月份,WellCare了结了2008年一宗涉及健康记录造假的欺诈丑闻,扫清了障碍,使WellCare再度跻身政府医疗照顾、医疗补助计划分包商的行列。 第三季度WellCare的新参保人数增加了10%,主要源于医疗照顾优先计划参保人数的增加。它帮助公司第三季度净利润翻了近乎一倍,并调高了前景预测。 WellCare同样也是潜在的收购目标。大型健康保险公司都急于提高在Medicare管理式医疗计划市场中的份额,今年美国联合健康集团(UnitedHealth Care)和信诺保险集团(Cign)都已收购了一些大型医疗照顾优先计划提供商。 | #1 WellCare Health Plans Ticker: WCG YTD stock performance: 93% Market cap: $2.2 billion Fortune 500 Rank: 420 As the first wave of baby boomers turns 65, WellCare is well poised to boost to take advantage. The Tampa, Fla., managed-care provider is the fourth-largest provider of Medicare Advantage insurance plans to seniors in the United States. Medicare Advantage, also known as Medicare Part C, is another option for Medicare recipients that mirror traditional insurance plans or offer supplemental coverage. In April, WellCare settled a 2008 fraud scandal involving falsifying health records. The settlement cleared the way for WellCare to once again be a government contractor for the Medicare and Medicaid programs. WellCare's enrollments jumped 10% in the third quarter, mostly due to an increase in Medicare Advantage members. The increase helped the firm nearly double its third-quarter profits and raise its outlook. WellCare also become a possible takeover target. Major health insurers have been scrambling to increase their market share in privately-managed Medicare plans, with UnitedHealth Care and Cigna (CI) already acquiring large Medicare Advantage providers this year. |
相关阅读:


